Skip to content
Homepage
Author:
Sharp Therapeutics
Posted Date:
May 28, 2026
Sharp Therapeutics Presents New Preclinical Data Supporting Novel Small-Molecule Therapeutic Approach for Niemann-Pick Disease Type C
Sharp Therapeutics
May 28, 2026
Sharp Therapeutics Appoints Co-Founder Of National Gaucher Foundation And Clinical Researcher Robin Ely, M.D., To Advisory Board
Sharp Therapeutics
January 27, 2026
